Renvela and Corgard drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Renvela and Corgard together.

The phase IV clinical study analyzes what interactions people who take Renvela and Corgard have. It is created by eHealthMe based on reports of 4 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

4 people who take Renvela and Corgard together, and have interactions are studied.


What is Renvela?

Renvela has active ingredients of sevelamer carbonate. eHealthMe is studying from 10,521 Renvela users for its effectiveness, alternative drugs and more.

What is Corgard?

Corgard has active ingredients of nadolol. It is often used in high blood pressure. eHealthMe is studying from 3,203 Corgard users for its effectiveness, alternative drugs and more.

Number of Renvela and Corgard reports submitted per year:

Renvela and Corgard drug interactions.

Common Renvela and Corgard drug interactions by gender *:

female:

  1. General physical health deterioration
  2. Headache
  3. Hot flush
  4. Hypercalcaemia
  5. Hyperglycaemia
  6. International normalised ratio increased
  7. Malignant neoplasm progression
  8. Tachycardia
  9. Leukocytoclastic vasculitis
  10. Vascular purpura

male:

  1. Device failure
  2. Bacterial test positive
  3. Haemorrhagic anaemia
  4. Post procedural complication
  5. Propionibacterium test positive

Common Renvela and Corgard drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Device failure
  2. Leukocytoclastic vasculitis
  3. Hot flush
  4. Hypercalcaemia
  5. Hyperglycaemia
  6. International normalised ratio increased
  7. Malignant neoplasm progression
  8. Post procedural complication
  9. Propionibacterium test positive
  10. Tachycardia

* Approximation only. Some reports may have incomplete information.

Do you take Renvela and Corgard?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Renvela and Corgard:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Renvela side effects:

Browse all side effects of Renvela:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Corgard side effects:

Browse all side effects of Corgard:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Renvela interactions:

Browse all interactions between Renvela and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Corgard interactions:

Browse all interactions between Corgard and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sevelamer carbonate and nadolol (the active ingredients of Renvela and Corgard, respectively), and Renvela and Corgard (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Renvela and Corgard.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: